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A case of dilated cardiomyopathy 
in a venezuelan patient with polymyositis
Abstract
Polymyositis is an autoimmune disease, characterized by the inflammation of muscular tissues. It belongs to 
the family of inflammatory myopathies, along with dermatomyositis, inclusion-bodies myositis and necrotizing 
autoimmune myositis. In this case report we present a 39 year old male patient admitted to the Bejuma District 
Hospital in October of 1991, where the patient is evaluated for 21 days. Electromyography, skeletal muscle biopsies, 
and further lab tests were performed; posing a diagnostic impression of Polymyositis. After the analysis of these 
results, the patient is discharged with pharmacological treatment; however, he denies taking the medications. 
In March of 2007 patient is seen at the Bejuma District Hospital after complaining of respiratory distress during 
mild efforts, concomitantly non-productive cough and palpitations. It is concluded that the rate of cardiovascular 
deterioration without constant medical treatment is secondary to untreated Polymyositis. 
Resumen
La polimiositis es una enfermedad autoinmune, caracterizada por la inflamación de los tejidos musculares. 
Pertenece a la familia de las miopatías inflamatorias, junto con dermatomiositis, miositis de cuerpos de inclu-
sión y miositis autoinmune necrotizante. En este caso presentamos un paciente varón de 39 años admitido 
en el Hospital del Distrito de Bejuma en octubre de 1991, donde el paciente es evaluado durante 21 días. Se 
realizaron electromiografía, biopsias del músculo esquelético y más pruebas de laboratorio; lo que supone 
una impresión diagnóstica de Polimiositis. Después del análisis de estos resultados, el paciente es dado de alta 
con tratamiento farmacológico; sin embargo, niega tomar los medicamentos. En marzo de 2007 el paciente es 
visto en el Hospital del Distrito de Bejuma después de quejarse de dificultad respiratoria durante los esfuerzos 
suaves, concomitantemente tos no productiva y palpitaciones. Se concluye que la tasa de deterioro cardiovas-
cular sin tratamiento médico constante es secundaria a la polimiositis no tratada.
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INTRODUCTION
Polymyositis is an autoimmune disease which belongs to the 
family of inflammatory myopathies, along with dermatomyositis, 
inclusion-bodies myositis and necrotizing autoimmune myositis (1,2). 
It affects the muscle tissue through an inflammatory and necrotizing 
process that results in progressive weakness. It may also affect the 
cardiac muscle. The average age of presentation ranges between 45 
and 60 years, and it seldom occurs during childhood (3).
Due to its uncommon nature; we present the study of a clinical 
case in which a patient with a diagnosis of Polymyositis attends to 
the Bejuma District Hospital, State of Carabobo, Venezuela, with 
manifestations of dilated cardiomyopathy class III.
CLINICAL CASE
Case of a 39-year-old patient from Carabobo, Venezuela, 
that started exhibiting symptoms of the disease in August of 
1991. The patient begins to exhibit proximal muscle weakness 
in the lower extremities in a progressive and symmetric 
manner. This progressive muscle weakness limits the patient’s 
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ability to perform daily activities like walking and stair 
climbing. Concomitantly, the patient presents with moderate 
myalgia that was unresponsive to NSAIDS. Due to persistent 
symptomatology, the patient is admitted to the Bejuma District 
Hospital in October of 1991, where the patient is evaluated 
for 21 days. Electromyography, skeletal muscle biopsies, 
and further lab tests were performed; posing a diagnostic 
impression of Polymyositis. The results showed a CPK ( 1435 
IU/L) and CK-MB (40 IU/L) elevation, electromyography of 
the anterior tibial, left vastus medialis, right deltoid, right 
quadriceps, right long supinator and left gastronecmius 
reported myopathic affection with proximal musculature 
predominance. After the analysis of these results, specialists 
concluded the diagnosis of Polymyositis. Oral Prednisone is 
indicated for 15 days. A Rheumatology service consultation 
is also requested. The patient did not follow treatment nor 
attended to the Rheumatologist evaluation.
In March of 2007, he returned to the center after 
complaining of respiratory distress during mild efforts, 
concomitantly non-productive cough and palpitations, which 
is why he was evaluated and admitted for 7 days. Physical 
examination showed: Patient in regular general conditions. 
Temperature: 36.5 ° C. Pulse: 100 b.p.m. Breathing: 20 b.p.m. 
Blood Pressure: 100 / 70mmHg. Hydrated skin without 
apparent lesions. Symmetric thorax, apex visible and palpable 
in 7th left intercostal space at 3cm outside of left midclavicular 
line, tachyarrhythmic cardiac sounds with holosystolic murmur 
grade II; Respiratory sounds present in both hemithorax with 
crackles in both pulmonary bases. Limbs showed decreased 
muscle strength in both upper limbs and mainly in lower 
limbs in its proximal portion, manifested by limitation to gait 
and incorporation in squatting position, muscular atrophy is 
evidenced at the predominance of bilateral femoral region, 
preserved osteotendinous reflexes, superficial and deep 
sensitivity conserved, no varices or edema are evident. Rest 
of the physical evaluation, without alterations. Machado 
Guerreiro test was negative, EKG showed Left Bundle Branch 
Blockade with Ventricular Extrasystoles, in the chest X-ray 
bibasal infiltrate, dilated cardiomyopathy is observed, and 
echocardiogram indicated dilated cardiomyopathy in four 
wells, left ventricular systolic function severely depressed with 
Ejection Fraction (EF) of 17% moderate mitral insufficiency, 
mild tricuspid insufficiency, without intracavitary thrombi. 
The patient is diagnosed with functional class III dilated 
cardiomyopathy.
After 7 days of hospitalizations the patient was discharged 
with Prednisolone P.O (1g/day) and medical treatment for 
cardiac insufficiency (lisinopril 2.5mg/day, spironolactone 
5mg/day, metoprolol 25mg/day).
DISCUSSION
Polymyositis is an idiopathic inflammatory disease whose 
prevalence is estimated in one case per 100,000 inhabitants 
per year in the general population and an incidence of 5 to 
10 cases per million in adults. The highest incidence occurs 
around the fifth decade of life and the woman / man ratio is 
2: 1 (3,7). Being a disease of unusual appearance it is often 
considered by many specialists as a diagnosis of exclusion (1).
The factors that trigger polymyositis are still unknown. 
The theory of a viral cause such as Coxsackie virus, influenza 
virus and HIV infection has been proposed, the latter being the 
most accepted because of the development of inflammatory 
myopathies in patients infected with a retrovirus. However, 
several studies have yielded conflicting results. Likewise, the 
effect of genetic factors and environmental agents has been 
hypothesized (1, 4). Our patient wasn’t aware of the presence 
of polymyositis in his family and also denied the history of a 
viral infection. The ELISA test for HIV reported a negative result.
The etiopathogenesis of this disease is believed to have 
an autoimmune basis. The presence of a direct cytotoxicity 
phenomenon restricted to the expression of class 1 antigens 
of the major histocompatibility complex has been evidenced. 
Polymyositis as an isolated entity is rare; more commonly it 
appears along with some other inflammatory disorder, being 
denominated “overlap syndrome”. These include: mixed 
connective tissue disease (MCTD), scleroderma myositis 
overlap syndrome, and the antisynthetase syndrome. It is 
common to see physical findings such as sclerodactyly and 
Raynaud’s phenomenon (1,2,4). Due to institutional and 
economical limitations, it was not possible to perform the 
necessary laboratories for the detection of antibodies related 
to these entities.
The diagnosis of inflammatory myositis is based on 
the presence of at least 3 clinical and laboratory findings, 
including: the presence of progressive weakness in the upper 
and lower extremities, elevation of muscle enzymes such as 
creatine kinase and transaminases, Electromyography and 
abnormal muscle biopsy. The presence of suggestive results in 
the aforementioned studies and the absence of dermatological 
findings such as Gottron’s papules and heliotrope rash excluded 
the possibility of a diagnosis of dermatomyositis (4,5). In our 
case, it would be necessary to do a differential diagnosis 
with Chagas disease, which can present peripheral muscle 
alterations, in addition to the characteristic heart affection. 
Due to its similar presentation, Chagas can be confused with 
Polymyositis (6). A test of Machado Guerreiro was indicated, 
which yielded negative results.
Among the various complications related to the diagnosis 
of polymyositis, the most common is the development of 
interstitial lung disease; which has been evidenced in almost 
75% of the cases (7,8,9). Cardiovascular complications have 
an approximated prevalence of 9 to 72% of cases (10) It has 
been hypothesized suggested that the development of cardiac 
complications are the sum of traditional cardiovascular 
risk factors plus the characteristic systemic inflammation 
in Polymyositis , which may explain the long period of time 
before the onset of cardiac symptoms in our patient. Cardiac 
symptomatology is often related to a bad prognosis in patients 
with Polymyositis The progress to systolic heart failure, has been 
documented in case reports, however, there are no controlled 
studies exposing this complication (11).). The development of 
cardiac insufficiency by cardiomyopathy tends to be observed 
in patients with important peripheral musculature affection 
(12,13). Electrocardiographic manifestations include branch 
block, A-V block, prolonged PR interval, left ventricular 
abnormalities, ventricular extrasystoles, high-grade cardiac 
block, Q-wave abnormalities, and non-specific changes in the 
ST segment (10).
Due to economical causes, in Venezuela we do not have 
the steroids sparing immunotherapy medications for the 
treatment of inflammatory myopathies.
With the presentation of this case report, we would 
like to highlight the relevance of a proper patient education 
and medical follow up, which are the keys in the prevention 
of long term complications. Even thought, in the Venezuelan 
public health system, we don’t always count with the necessary 
diagnostic and therapeutic tools, we as physicians try to prioritize 
the use of a good clinical eye and a complete medical history to 
obtain the correct diagnosis give the best treatment option.
Acknowledgement: Bejuma District Hospital Epidemiology 
Service.
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